RAYMOND JAMES & ASSOCIATES - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 325 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,134,766
+1.8%
29,582
+56.1%
0.00%0.0%
Q1 2024$1,114,175
+21.0%
18,955
+23.2%
0.00%0.0%
Q4 2023$921,066
-42.4%
15,387
-63.4%
0.00%0.0%
Q3 2023$1,598,441
-61.5%
42,020
-7.7%
0.00%
-66.7%
Q2 2023$4,149,601
+2.2%
45,550
-26.0%
0.00%
-25.0%
Q1 2023$4,058,383
+443.6%
61,528
+326.2%
0.00%
+300.0%
Q4 2022$746,537
-22.1%
14,437
+2.9%
0.00%0.0%
Q3 2022$958,000
+163.2%
14,032
+74.3%
0.00%
Q2 2022$364,000
+12.3%
8,049
+26.1%
0.00%
Q1 2022$324,000
+0.3%
6,385
-6.7%
0.00%
Q4 2021$323,000
+35.1%
6,840
-5.7%
0.00%
Q3 2021$239,000
-49.7%
7,256
-3.5%
0.00%
Q2 2021$475,000
-28.7%
7,520
-51.5%
0.00%
-100.0%
Q1 2021$666,000
+88.7%
15,518
+151.2%
0.00%
Q4 2020$353,000
+68.1%
6,178
-3.8%
0.00%
Q2 2020$210,000
-4.1%
6,422
-21.4%
0.00%
Q1 2020$219,0008,1750.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders